关注
Judit Kállai
Judit Kállai
在 med.unideb.hu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients
L Balogh, É Katona, ZA Mezei, J Kállai, R Gindele, I Édes, L Muszbek, ...
Molecular and Cellular Biochemistry 448, 199-209, 2018
182018
Deficiencies of the natural anticoagulants–novel clinical laboratory aspects of thrombophilia testing
Z Bereczky, R Gindele, M Speker, J Kállai
Ejifcc 27 (2), 130, 2016
172016
Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism
ZA Mezei, É Katona, J Kállai, Z Bereczky, L Somodi, É Molnár, B Kovács, ...
Thrombosis research 158, 93-97, 2017
142017
Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c. 1952+ 144 C> G polymorphism
ZA Mezei, É Katona, J Kállai, Z Bereczky, É Molnár, B Kovács, É Ajzner, ...
Thrombosis research 148, 101-106, 2016
122016
Investigation of the differences in antithrombin to heparin binding among antithrombin Budapest 3, Basel, and Padua mutations by biochemical and in silico methods
R Gindele, K Pénzes-Daku, G Balogh, J Kállai, R Bogáti, B Bécsi, ...
Biomolecules 11 (4), 544, 2021
112021
A novel mutation in SLC39A7 identified in a patient with autosomal recessive agammaglobulinemia: The impact of the J Project
M Erdős, K Mironska, L Kareva, K Stavric, A Hasani, Á Lányi, J Kállai, ...
Pediatric Allergy and Immunology 33 (6), 2022
62022
Resolving differential diagnostic problems in von willebrand disease, in fibrinogen disorders, in prekallikrein deficiency and in hereditary hemorrhagic telangiectasia by next …
R Gindele, A Kerényi, J Kállai, G Pfliegler, Á Schlammadinger, I Szegedi, ...
Life 11 (3), 202, 2021
62021
Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype
M Erdős, M Tsumura, J Kállai, Á Lányi, Z Nyul, G Balázs, S Okada, ...
Clinical & Experimental Immunology 205 (3), 354-362, 2021
52021
The Voltage-Gated Hv1 H+ Channel Is Expressed in Tumor-Infiltrating Myeloid-Derived Suppressor Cells
M Cozzolino, A Gyöngyösi, E Korpos, P Gogolak, MU Naseem, J Kállai, ...
International Journal of Molecular Sciences 24 (7), 6216, 2023
42023
Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism
B Baráth, R Bogáti, T Miklós, J Kállai, ZA Mezei, Z Bereczky, L Muszbek, ...
Thrombosis Research 203, 110-116, 2021
22021
Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
K Szegedi, Z Szabó, J Kállai, J Király, E Szabó, Z Bereczky, É Juhász, ...
Journal of Clinical Medicine 12 (13), 4538, 2023
12023
5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel
TG Szanto, A Feher, E Korpos, A Gyöngyösi, J Kállai, B Mészáros, K Ovari, ...
Pharmaceuticals 16 (5), 656, 2023
12023
Topically applied N, N-Dimethylglycine Sodium Salt Enhances Human Skin Blood Flow by Inducing Endothelial Nitric Oxide Release
G Béke, A Lendvai, E Hollósi, N Braun, C Theek, J Kállai, Á Lányi, ...
The Journal of investigative dermatology, S0022-202X (24) 00383-X, 2024
2024
Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations
J Kállai, R Gindele, K Pénzes-Daku, G Balogh, R Bogáti, B Bécsi, ...
International Journal of Molecular Sciences 25 (5), 2893, 2024
2024
Identification of a new family of inhibitors of the human Hv1 proton channel
A Feher, E Korpos-Pintye-Gyuri, M Piga, T Tomasic, N Zidar, A Gyongyosi, ...
Biophysical Journal 122 (3), 256a-257a, 2023
2023
A novel mutation in SLC39A7 identified in a patient with autosomal recessive agammaglobulinemia
M Erdős, K Mironska, L Kareva, K Stavrik, A Hasani, A Lanyi, J Kallai, ...
Authorea Preprints, 2022
2022
Feno-and genotyping von Willebrand disease type 2A patient because of spontaneous tonsilliar haemorrhage
J Harsfalvi, ML Udvardy, J Kallai, A Kerenyi, I Szegedi, E Marjan, C Kiss
JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11, 1181-1181, 2013
2013
Rizs protein foszfatáz 2A B''alegység expressziójára alkalmas vektorkonstrukciók készítése
J Kállai
A novel mutation in identified in a patient with autosomal recessive agammaglobulinemia: the impact of the J-Project
M Erdős, K Mironska, L Kareva, K Stavrik, A Hasani, Á Lányi, J Kállai, ...
系统目前无法执行此操作,请稍后再试。
文章 1–19